文章摘要
赵建国,熊建萍,张凌.艾迪注射液联合化疗治疗晚期胃癌的临床研究[J].江西中医药大学学报,2009,21(1):17-20. |
艾迪注射液联合化疗治疗晚期胃癌的临床研究 |
Aidi Injection Combined with Chemotherapy in Advanced Gastric Cancer |
投稿时间:2008-07-29 |
DOI: |
中文关键词: 艾迪注射液;晚期胃癌;化疗;毒性;生活质量 |
英文关键词: |
基金项目: |
赵建国1,熊建萍2,张凌2 |
1.浙江省绍兴市人民医院,绍兴312000;2.南昌大学第一附属医院,南昌330006 |
摘要点击次数: 6942 |
全文下载次数: 9819 |
中文摘要: |
目的:观察艾迪注射液联合TX(紫杉醇+卡培他滨)方案化疗治疗晚期胃癌患者的疗效、毒性反应及对生活质量的影响。方法:62例晚期胃癌患者随机分为艾迪联合化疗组(治疗组)及单纯化疗组(对照组),其中治疗组32例,对照组30例。评价两组患者近期疗效、毒性反应及生活质量。结果:治疗组与对照组近期疗效分别为53.1%和40.0%(P>0.05);治疗组血液及非血液毒性均低于对照组(P<0.05);治疗组生活质量明显改善(P<0.05)。结论:艾迪注射液联合化疗治疗晚期胃癌,能 |
英文摘要: |
Objective:To evaluate the efficacy and toxicity and the effect on quality of life (QOL) in advanced gastric cancer patients treated by Aidi injection combined with TX regimens.Methods:Sixty-two patients with advanced Gastric cancer were randomly divided into two groups:treatment group(n=32) received Aidi injection and chemotherapy,and control group(n=30)only accepted chemotherapy.The response rate and toxicity and QOL were compared in two groups.Results:The response rate of treatment group was 53.1% and control group was 40.0% (P>0.05),The treatment group had less toxicity than control group(P<0.05),and the QOL raised significantly(P<0.05).Conclusion:Aidi injection combined with chemotherapy can reduce the toxicity and improve the QOL. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |
|
|
|
|
|